The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex

Addiction Biology

Volumn 20, Issue 4, 2015, Pages 701-713

  Ogbonmwan, Yvonne E ^a   Sciolino, Natale R ^b   Groves Chapman, Jessica L ^b   Freeman, Kimberly G ^b   Schroeder, Jason P ^a   Edwards, Gaylen L ^b   Holmes, Philip V ^b,c   Weinshenker, David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c University of Georgia   (United States)

Author keywords

Cocaine; cortex; dopamine; galanin; galnon; reinstatement

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; COCAINE; DOPAMINE; GALANIN RECEPTOR; GALNON; UNCLASSIFIED DRUG; 7-((9-FLUORENYLMETHOXYCARBONYL)CYCLOHEXYLALANYLLYSYL)AMINO-4-METHYLCOUMARIN; COUMARIN DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; GALANIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE TREATMENT; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FRONTAL CORTEX; MALE; MOTOR ACTIVITY; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINSTATEMENT; ANIMAL; ANTAGONISTS AND INHIBITORS; COCAINE-RELATED DISORDERS; DRUG EFFECTS; EATING; FRONTAL LOBE; INSTRUMENTAL CONDITIONING; METABOLISM; MICRODIALYSIS; PATHOPHYSIOLOGY; RECURRENT DISEASE; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; COUMARINS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG-SEEKING BEHAVIOR; EATING; EXTINCTION, PSYCHOLOGICAL; FRONTAL LOBE; GALANIN; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS, SPRAGUE-DAWLEY; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 84930822954     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12166     Document Type: Article

References (50)

1. Abramov U, Floren A, Echevarria DJ, Brewer A, Manuzon H, Robinson JK, Bartfai T, Vasar E, Langel U, (2004) Regulation of feeding by galnon. Neuropeptides 38: 55-61.
2. Anderson ME, Runesson J, Saar I, Langel U, Robinson JK, (2013) Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behavior. Behav Brain Res 239: 90-93.
3. Bartfai T, Wang MW, (2013) Positive allosteric modulators to peptide GPCRs: a promising class of drugs. Acta Pharmacol Sin 34: 880-885.
4. Bossert JM, Marchant NJ, Calu DJ, Shaham Y, (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229: 453-476.
5. Brabant C, Kuschpel AS, Picciotto MR, (2010) Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin. Behav Neurosci 124: 828-838.
6. Chen YI, Famous K, Xu H, Choi JK, Mandeville JB, Schmidt HD, Pierce RC, Jenkins BG, (2011) Cocaine self-administration leads to alterations in temporal responses to cocaine challenge in limbic and motor circuitry. Eur J Neurosci 34: 800-815.
7. Cornish JL, Kalivas PW, (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20: RC89.
8. Doherty MD, Gratton A, (1996) Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Brain Res 715: 86-97.
9. Einstein EB, Asaka Y, Yeckel MF, Higley MJ, Picciotto MR, (2013) Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2. Eur J Neurosci 37: 1541-1549.
10. Floren A, Sollenberg U, Lundstrom L, Zorko M, Stojan J, Budihna M, Wheatley M, Martin NP, Kilk K, Mazarati A, Bartfai T, Lindgren M, Langel U, (2005) Multiple interaction sites of galnon trigger its biological effects. Neuropeptides 39: 547-558.
11. Hawes JJ, Picciotto MR, (2004) Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J Comp Neurol 479: 410-423.
12. Hawes JJ, Brunzell DH, Narasimhaiah R, Langel U, Wynick D, Picciotto MR, (2008) Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology 33: 1864-1873.
13. Holmes FE, Armenaki A, Iismaa TP, Einstein EB, Shine J, Picciotto MR, Wynick D, Zachariou V, (2012) Galanin negatively modulates opiate withdrawal via galanin receptor 1. Psychopharmacology (Berl) 220: 619-625.
14. Jackson KJ, Chen X, Miles MF, Harenza J, Damaj MI, (2011) The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence. Neuropsychopharmacology 36: 2339-2348.
15. Jansson A, Fuxe K, Eneroth P, Agnati LF, (1989) Centrally administered galanin reduces dopamine utilization in the median eminence and increases dopamine utilization in the medial neostriatum of the male rat. Acta Physiol Scand 135: 199-200.
16. Kalivas PW, (2007) Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9: 389-397.
17. King D, Zigmond MJ, Finlay JM, (1997) Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 77: 141-153.
18. Lindvall O, Bjorklund A, Divac I, (1978) Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res 142: 1-24.
19. Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T, (2005a) A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci U S A 102: 874-879.
20. Lu X, Lundstrom L, Langel U, Bartfai T, (2005b) Galanin receptor ligands. Neuropeptides 39: 143-146.
21. McFarland K, Kalivas PW, (2001) The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21: 8655-8663.
22. McFarland K, Lapish CC, Kalivas PW, (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23: 3531-3537.
23. McNamara IM, Robinson JK, (2010) Conditional stimulation by galanin of saccharin and ethanol consumption under free and response contingent access. Neuropeptides 44: 445-451.
24. Melander T, Hokfelt T, Rokaeus A, Cuello AC, Oertel WH, Verhofstad A, Goldstein M, (1986) Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 6: 3640-3654.
25. Melander T, Fuxe K, Harfstrand A, Eneroth P, Hokfelt T, (1987) Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat. Possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol Scand 131: 25-32.
26. Morales M, Pickel VM, (2012) Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system. Ann N Y Acad Sci 1248: 71-88.
27. Narasimhaiah R, Kamens HM, Picciotto MR, (2009) Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice. Psychopharmacology (Berl) 204: 95-102.
28. Neugebauer NM, Henehan RM, Hales CA, Picciotto MR, (2011) Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav 98: 87-93.
29. Nordstrom O, Melander T, Hokfelt T, Bartfai T, Goldstein M, (1987) Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci Lett 73: 21-26.
30. Paxinos G, Watson C, (1998) The Rat Brain: in Stereotaxic Coordinates, 4th edn. San Diego: Academic Press.
31. Picciotto MR, (2008) Galanin and addiction. Cell Mol Life Sci 65: 1872-1879.
32. Pycock CJ, Carter CJ, Kerwin RW, (1980) Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem 34: 91-99.
33. Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, Ring RH, Schechter LE, Rosenzweig-Lipson S, Beyer CE, (2007) Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon. Neuropeptides 41: 307-320.
34. Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hokfelt T, Wasterlain C, Bartfai T, Langel U, (2002) Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci U S A 99: 7136-7141.
35. Santiago M, Westerink BH, (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch Pharmacol 342: 407-414.
36. Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC, (2005) Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526: 65-76.
37. Schroeder JP, Cooper DA, Schank JR, Lyle MA, Gaval-Cruz M, Ogbonmwan YE, Pozdeyev N, Freeman KG, Iuvone PM, Edwards GL, Holmes PV, Weinshenker D, (2010) Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase. Neuropsychopharmacology 35: 2440-2449.
38. Schroeder JP, Epps SA, Grice TW, Weinshenker D, (2013) The selective dopamine beta-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology 38: 1032-1038.
39. Sciolino NR, Dishman RK, Holmes PV, (2012) Voluntary exercise offers anxiolytic potential and amplifies galanin gene expression in the locus coeruleus of the rat. Behav Brain Res 233: 191-200.
40. Sinha R, (2009) Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14: 84-98.
41. Soares J, Holmes PV, Renner KJ, Edwards GL, Bunnell BN, Dishman RK, (1999) Brain noradrenergic responses to footshock after chronic activity-wheel running. Behav Neurosci 113: 558-566.
42. Sollenberg U, Bartfai T, Langel U, (2005) Galnon-a low-molecular weight ligand of the galanin receptors. Neuropeptides 39: 161-163.
43. Sun W, Rebec GV, (2005) The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology (Berl) 177: 315-323.
44. Tritsch NX, Sabatini BL, (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76: 33-50.
45. Tsuda K, Tsuda S, Nishio I, Masuyama Y, Goldstein M, (1998) Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am J Hypertens 11: 1475-1479.
46. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S, (2004) Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 29: 72-80.
47. Wu WP, Hao JX, Lundstrom L, Wiesenfeld-Hallin Z, Langel U, Bartfai T, Xu XJ, (2003) Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury. Eur J Pharmacol 482: 133-137.
48. Xu ZQ, Zheng K, Hokfelt T, (2005) Electrophysiological studies on galanin effects in brain-progress during the last six years. Neuropeptides 39: 269-275.
49. Zachariou V, Parikh K, Picciotto MR, (1999) Centrally administered galanin blocks morphine place preference in the mouse. Brain Res 831: 33-42.
50. Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR, (2003) The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci U S A 100: 9028-9033.